Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis
JACC: Clinical Electrophysiology · 2026-05 · 12 (5) · 1131-1142
DOI: 10.1016/j.jacep.2026.01.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026-05. Verfasst von Thibaut Moulin und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France. Electronic address: thibautmoulin…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Death, Sudden, Cardiac, Immunoglobulin Light-chain Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Sudden cardiac death represents a common mode of death in patients with light chain cardiac amyloidosis (AL CA). However, data evaluating the role of implantable cardioverter defibrillator (ICD) in these patients are scarce. OBJECTIVES: This study aimed to describe the incidence and identify factors associated with appropriate ICD therapies in AL CA patients. METHODS: This was a retrospective, single referral center study including all AL CA patients implanted with ICDs between November 2014 and May 2024. The primary endpoint was the first appropriate ICD therapy (shock or antitachycardia pacing). RESULTS: A total of 150 patients (mean age 63.4 ± 9.2 years, 65.3% male) were included, all with primary prevention ICDs. Over a median follow-up period of 16.8 months (Q1-Q3: 5.4-56.5 months), 27 (18.0%) patients received at least 1 appropriate ICD therapy (1-year cumulative incidence: 11.6%; 95% CI: 7.4%-18.2%; 5-year cumulative incidence: 19.5%; 95% CI: 13.4%-28.4%). In multivariate analysis, impaired left ventricular (LV) global longitudinal strain was independently associated with a higher risk of appropriate ICD therapy (optimal cutoff -9.5%; adjusted subdistribution HR: 5.33; 95% CI: 1.99-14.26; P = 0.0009). CONCLUSIONS: AL CA patients implanted with prophylactic ICDs experience high rates of appropriate therapies. Assessment of LV involvement with LV global longitudinal strain might improve risk stratification for ventricular arrhythmias. Further studies are needed to assess the impact of ICD on overall survival in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France. Electronic address: thibautmoulin6@gmail.com.
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France; French Referral Center for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Netw…
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France.
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France; Department of Cardiology, Intercommunal Hospital of Villeneuve Saint Georges, Villeneuve Saint Georges,…
- Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France; Department of Cardiology, Saint Camille Hospital, Bry-sur-Marne, France.
- French Referral Center for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Network, Créteil, France; DHU A-TVB, Henri Mondor Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, Fra…
Zitieren
APA
Moulin, T., Zaroui, A., Ramoul, K., Rouffiac, S., Kharoubi, M., Djouadi, K., Guendouz, S., Elbaz, N., Ouazana, V., Labbé, J. P., Galat, A., Gounot, R., Belhadj, K., Lemonnier, F., Dhanjal, T. S., Le Corvoisier, P., Audureau, E., Teiger, E., Oghina, S., …, & Lellouche, N. (2026). Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis. JACC: Clinical Electrophysiology, 12(5), 1131-1142. https://doi.org/10.1016/j.jacep.2026.01.010
Vancouver
Moulin T, Zaroui A, Ramoul K, Rouffiac S, Kharoubi M, Djouadi K, et al. Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis. JACC: Clinical Electrophysiology. 2026;12(5):1131-1142. doi:10.1016/j.jacep.2026.01.010
BibTeX
@article{Moulin2026,
author = {Moulin, Thibaut and Zaroui, Amira and Ramoul, Khaled and Rouffiac, Ségolène and Kharoubi, Mounira and Djouadi, Kamila and Guendouz, Soulef and Elbaz, Nathalie and Ouazana, Victoria and Labbé, Jean-Philippe and Galat, Arnault and Gounot, Romain and Belhadj, Karim and Lemonnier, François and Dhanjal, Tarvinder S and Le Corvoisier, Philippe and Audureau, Etienne and Teiger, Emmanuel and Oghina, Silvia and Damy, Thibaud and Lellouche, Nicolas},
title = {Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
volume = {12},
number = {5},
pages = {1131--1142},
doi = {10.1016/j.jacep.2026.01.010}
}
EUVIMED